4th Quarter - Report

CENCORA, INC. for CENCORA, INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$277,800
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Feb 1, 2010 $277,800 Replaced
4th Quarter - Amendment Apr 20, 2010 $380,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R. 1392 and S. 1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price.

LobbyistCovered position, as disclosed
RITA E NORTON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1392 (111th), S. 1221 (111th)

Pharmacy PHA

H.R. 1392 and S. 1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price.

LobbyistCovered position, as disclosed
RITA E NORTON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1221 (111th), H.R. 1392 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.